Abstract

1. The benzophenanthrine alkaloid, sanguinarine, was studied for its effects on isolated mouse phrenic-nerve diaphragm preparations. Sanguinarine induced direct, dose-dependent effects on muscle contractility. 2. Sanguinarine-induced contracture was partially inhibited when the extracellular Ca 2+ was removed or when the diaphragm was pretreated with nifedipine. Depletion of sarcoplasmic reticulum (SR) internal calcium stores completely blocked the contracture. 3. Sanguinarine induced Ca 2+ release from the actively loaded SR vesicles was blocked by ruthenium red and dithiothreitol (DTT), consistent with the ryanodine receptor (RyR) as the site of sanguinarine action. 4. Sanguinarine altered [ 3H]-ryanodine binding to the RyR of isolated SR vesicles, potentiating [ 3H]-ryanodine binding at lower concentrations and inhibiting binding at higher concentrations. All of these effects were reversed by DTT, suggesting that sanguinarine-induced Ca 2+ release from SR occurs through oxidation of critical SH groups of the RyR SR calcium release channel.

Original languageEnglish
Pages (from-to)299-306
Number of pages8
JournalBritish Journal of Pharmacology
Volume130
Issue number2
DOIs
Publication statusPublished - 2000

Keywords

  • Contracture
  • Ryanodine receptor
  • Sanguinarine
  • Skeletal muscle

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Induction of skeletal muscle contracture and calcium release from isolated sarcoplasmic reticulum vesicles by sanguinarine'. Together they form a unique fingerprint.

Cite this